 The Genomic Medicine Working Group's GM8, those of you who are interested in GMs 1 through 7, there's plenty of information on the web, and GM8 is now starting. And the point of all these have been trying to identify where progress is being made, where there are gaps, trying to make certain things happen, like we're working with payers, we've worked with a lot of other groups at past meetings to try to really stimulate things to happen in the field. And with this particular working group, we were focusing on the NIH portfolio, in particular the NHGRI portfolio, but also looking across the different ICs, and identifying where work is happening, but also where there are gaps that need to be filled. And as Terry will show, past meetings have resulted in not only nice white papers that were published, but also RFAs for the extramural community, intramural opportunities across ICs and such. So the goal is not to have lost two days in Bethesda, but rather to produce something that would really go forward, and certainly NHGRI has a history of using these gatherings for real planning and real implementation. So I think from that standpoint, it's going to be quite useful. We have a lot of representation from across the United States, across North America, and in a few cases across the world. And so one of the things we can do to start is go around and introduce ourselves. There will be other opportunities to get to know each other as well throughout the day. But I'm Howard McLeod from Moffitt Cancer Center in Tampa, Florida, and it's freezing up here. I've never been this cold since I moved down there. But other than that, I'm looking forward to the day. And maybe we can start down at the instance, you were getting ready to take a bite and we'll go ahead and start with you. You did that on purpose. I'm Steve Jaffee. I'm in the Department of Medical Ethics and Health Policy at Penn. I'm also a pediatric oncologist, and I'm involved with one of the CSER projects, the Dana-Farber Project. Janet Williams. I'm a genetic counselor at Geisinger. I'm in the genomic medicine department. Work on the eMERGE projects as well as a PCORI-funded project. I'm Julie Johnson from University of Florida, and PI of one of the Ignite-funded projects. I'm Wendy Rubenstein, medical geneticist at NCBI. Work on genetic testing registry, GTR. Work on ClinVar and MedGen, and I'm also involved in the ISCC, one of the reasons I'm here. I'm Stephen Kingsmore from Children's Mercy Kansas City, and I'm the PI of one of the Insight Grants. Cynthia Powell. I'm a clinical geneticist and pediatrician and co-PI of one of the Insight Grants, the one at the University of North Carolina. I'm Bob Framath from Mayo Clinic. I do medical informatics looking at the pharmacogenomics of clinical decision support. I'm involved with the PGRN and the eMERGE projects. I'm Mike Guziano. I'm a VA Boston, Brigham Women's Hospital Heart of Med School, and I'm PI of the Million Veteran Program. I'm Dan Rodin from Vanderbilt. I work on eMERGE, on the Pharmacogenetics Research Network, and I am on NHGRI advisory council right now. And I think no one has yet managed to introduce themselves without using at least three acronyms. Jeff Ginsberg from Duke University. I'm PI of one of the Ignite projects and also a member of the GMWG for NHGRI. I'm Mary Relling at St. Jude Children's Research Hospital. I'm the incoming chair of the Pharmacogenomics Research Network, and I'm the leader of the CPIC for implementation of pharmacogenomics, and I'm also part of the GMWG. Mark Williams, I'm the director of the Genomic Medicine Institute at Geisinger, a member of the Genomic Medicine Working Group and chairing the panel for. And Howard, you've met. I'm Terry Monoglio. I lead the division of Genomic Medicine here at the Genome Institute. Rex Chisholm, Northwestern University in Chicago, PI of one of the eMERGE sites and also a member of the GMWG. I'm Carol Bolt, professor and deputy director of the Cancer Center at the Jackson Laboratory, Bar Harbor, Maine, on NHGRI council and a member of the working group. Eric Green, director of NHGRI. I'll have a few more things to say as soon as we finish going around the room introducing ourselves. Howard Jacob, currently at the Medical College of Wisconsin for four weeks, and then I'll be at Hudson Alpha in Huntsville, Alabama. And I think this is hot, Howard. I think I'm in trouble. I am a member of the working group and also an NHGRI council. Chris Shoot, Johns Hopkins, PI of one of the eMERGE grants and also on the External Scientific Advisory Committee of Ignite. Alexa McRae, Harvard Medical School and one of the PI's of the Undiagnosed Diseases Network. Excuse me, Warwick Anderson, until recently head of the Australian National Health and Medical Research Council and shortly of the Human Frontier Science Program. Good morning, Ruth Brenner, chief of the Air Force Medical Service Personalized Medicine Program. Sharon Plon, Baylor College of Medicine. I'm one of the PI's of one of the clinical sequencing exploratory research or CSER sites and I'm one of the ClinGen PI's. Robert Green, Brigham and Women's Hospital. I'm primarily involved with CSER and INSITE and have small roles on some of the other acronyms. Katrina Goddard at Kaiser Permanente Northwest in Portland, Oregon. I'm a PI on one of the CSER sites and I chair the Action Availability Work Group for the ClinGen project. Gail Jarbeck, head of Medical Genetics at the University of Washington. I'm a PI on Emerge and CSER and have a supporting role for the Center for Mendelian Genetics. Heidi Rehm from Harvard Medical School. I'm a PI on the ClinGen project and also involved in CSER and INSITE. Jonathan Berg, I'm a clinical geneticist at the University of North Carolina at Chapel Hill. I'm one of the co-PIs on a CSER project at UNC, INSITE project and ClinGen. Good morning, Pierre Moulien from Genome Canada. We run a relatively large program, Genomics and Personalized Health in Canada. I'd like to thank the organizers for including Canada in your deliberations. Thank you and hope we have a very constructive day. Thank you. Good morning, Gurbani Trandeva from Agency for Healthcare Research and Quality from Rockwell. Ele, I know you have been here for 24 hours or whatever at NHGRI, could you start off this row? Hi, I'm Ele Silverman and I'm a program analyst at NHGRI. I'm Jackie Ogis. I'm program analyst for the Genomic Medicine Working Group. Heidi Sovia, Program Director at NHGRI. Louise Witterhoff and I'm a program director on detail to NHGRI. Erin Ramos, Division of Genomic Medicine, I'm the Program Director for ClinGen and Phoenix. Barb Conley, I'm a medical oncologist, currently Associate Director of Cancer Diagnosis Program and here on behalf of the Division of Cancer Treatment and Diagnosis for a couple of NCI genomically with trials with genomic eligibility. Jeff Struing from the Division of Genomic Medicine at NHGRI. Annie Nehouse, Division of Genomic Medicine, I'm the Analyst on ClinGen. I'm Carolyn Header. I'm also a Program Director in the Division of Genomic Medicine at NHGRI and I work primarily on the cancer genome atlas and the clinical sequencing exploratory research programs as well as a little bit on ClinGen and some other, oh and the large-scale sequencing program and some other things. I'm Jeff Schloss, the Director of Division of Genome Sciences at NHGRI. Mike Pazin, I'm a Program Director and Division of Genome Sciences at Genome. I'm Tina Erf from NICHD. I'm a Program Director along with Anastacia Wise on the Insight Program. I'm Epidemiologist at the Division of Genomic Medicine and I'm one of the Program Directors for NIGHT. I'm Heather Junkins, I'm a Program Director in the Division of Genomic Medicine. I work on the Ignite Program and the Training and Career Programs. Lucia Hendoor, Division of Genomic Medicine, Program Director. I work on the CSER Project, the Population Architecture Using Genomic and Epidemiology or Page Program on the GWAS Catalog. I'm Ken Wiley, Program Director, Division of Genomic Medicine at NHGRI. Oh, I want to, do we miss anyone? So I want to thank all of you for making time. I know that some of you are on this coast for today and then zipping back to watch your daughter graduate or other things like that and many of you have crossed ponds and big and small. So thank you all for your effort and for everything you've brought. Thank you to me, the three folks along here, since you've sat down for almost 10 seconds, could introduce yourself before Eric, make some comments. Hi, I'm Sherry Shelly, currently at the NCI, moving soon to the NIHOD. I'm Santataminnia and I'm from the National Eye Institute. Elise Feingold, NHGRI.